Latest News

In October 2025, Asian markets are navigating a complex landscape marked by mixed economic signals and evolving monetary policies. As investors seek opportunities in this environment, identifying stocks that appear undervalued can be a strategic approach to potentially capitalize on market inefficiencies.

Deciding what to do with Amrize at this moment can feel a bit like standing at a crossroads. Maybe you have watched the price tick up 2.4% over the last week and wondered if this is the start of a comeback. At the same time, the stock is still down 9.0% for the past 30 days and has lost 16.4% so far this year, reflecting the market’s uncertainty and shifting appetite for risk in this sector. Some recent developments in the broader market seem to have nudged investors’ perception of Amrize,...

Bisalloy Steel Group recently issued 75,632 unquoted performance share rights as part of an employee incentive scheme, and announced its 2025 Annual General Meeting to be held virtually on November 6. These initiatives focus on aligning employee interests with company goals and providing greater transparency on strategic direction for stakeholders. We'll explore how Bisalloy's stepped-up employee engagement through performance share rights could influence its future investment...

Bakkt Holdings recently completed the sale of its loyalty business and appointed fintech veteran Mike Alfred to its board, marking a shift to a focused digital asset infrastructure platform. This transformation is underscored by renewed emphasis on Bitcoin, tokenized payments, and zero debt, signaling a significant realignment toward crypto and digital finance services. We'll explore how the company’s sharpened focus on digital assets and new leadership shapes Bakkt Holdings' investment...

SMC (TSE:6273) caught investors’ attention after CLSA elevated its stock rating. The move highlights the company’s solid global standing and expected tailwinds from future growth in technology and semiconductor production equipment. See our latest analysis for SMC. SMC’s recent share buyback completion and the upgrade from CLSA have set a more optimistic tone for investors, even as the company navigates a period of softer earnings and reduced guidance. While the total shareholder return over...

If you are staring at Fulton Financial’s ticker and wondering what comes next, you are not alone. The stock has quietly caught the eye of both cautious and optimistic investors after years of solid, if occasionally bumpy, performance. While volatility has crept in recently, with the price slipping -2.9% in the past week and -5.3% over the last month, the longer-term story is hard to ignore. Shares are up 10% over the past year, and an impressive 118.3% over five years, which suggests that...

David Iben put it well when he said, 'Volatility is not a risk we care about. What we care about is avoiding the...

Alto Neuroscience just received Fast Track designation from the FDA for ALTO-101, a new drug candidate aimed at treating cognitive impairment related to schizophrenia. This move could accelerate ALTO-101’s development and review process. See our latest analysis for Alto Neuroscience. The FDA’s support for ALTO-101 sparked fresh interest in Alto Neuroscience. However, despite the headline, its 1-year total shareholder return remains nearly flat while recent share price momentum has been...

If you are wrestling with the question of what to do with JD Logistics stock right now, you are not alone. Shares closed at 12.89 in the latest session and while the company's price hasn’t exactly skyrocketed lately, there are clear signals that the market's perception is quietly shifting. Over the last seven days, the stock notched a 0.5% gain. Over thirty days, it's up by 1.5%, and so far this year, JD Logistics has inched forward by 1.7%. Yet, if we zoom out, the one-year performance...

Are you eyeing Voestalpine and wondering if now is your moment to invest, hold, or walk away? You're not alone. After a year of eye-catching gains, this stock has many talking, and for good reason. Voestalpine has soared an impressive 81.7% year-to-date, with the past 30 days alone bringing investors a robust 15.2% return. Even looking beyond the short term, the stock is up nearly 100% over three years and 63.9% over five years. These moves hint at renewed optimism but may also reflect shifts...

Trying to figure out what to do with Saipem stock? You are not alone. Whether you are a new investor or someone tracking your positions closely, there is plenty to unpack behind this company’s recent moves. In just the past month, Saipem shares have climbed 10.2%, adding to a huge 32.6% surge over the past year. Even after some bumps earlier this year, and a five-year performance still showing a loss of 30.8%, the stock has more than tripled (up 272.4%) in the last three years. Those kinds of...

Yunfeng Financial Group (SEHK:376) has just been added to the S&P Global BMI Index, an event that often attracts the attention of investors and index funds. Index inclusions like this can generate new trading interest and increase liquidity. See our latest analysis for Yunfeng Financial Group. Shares have gained momentum following the S&P Global BMI Index inclusion, with a recent share price return of 5.1% year-to-date and a steady 3.7% total shareholder return over the past year, which hints...

As the Australian market experiences a slight pullback following a bullish surge, investors are keenly observing the ASX 200's movements amidst fluctuating global economic factors such as U.S. government shutdown concerns and rising gold prices. In this context, identifying undervalued stocks can be particularly appealing, as they may offer potential opportunities for growth in a market that is currently experiencing volatility and consolidation.

Trying to decide what to do with Chemed stock right now? You are not alone. Shareholders and would-be investors alike have been watching the company’s journey with a mix of curiosity and concern. After all, Chemed’s story over the past year has not followed a gentle upward climb. Instead, it has seen some notable slides, including a 16.0% drop year-to-date and an even steeper 23.4% decline over the past 12 months. Even stretching out to five years, Chemed’s shares are down 5.9%, which can...

Thinking about your next move with American Homes 4 Rent? You are not alone. The real estate sector has kept investors guessing lately, and American Homes 4 Rent has seen its fair share of ups and downs. Over the past week, the stock held steady with a slight 0.1% bump, but the 30-day drop of 6.3% and a year-to-date slide of 11.2% might be giving some pause. Long-term holders have still netted a gain, with more than 22% over five years, but recent dips have many wondering whether there is...

In recent weeks, ProAssurance received a consensus "Hold" recommendation from six ratings firms, while Zacks Research raised its rating to "strong-buy" and institutional investors and hedge funds significantly increased their shareholdings. This combination of analyst upgrade and heightened institutional interest signals a shift in market sentiment and renewed confidence in the company’s outlook. We’ll examine how the increased institutional ownership may impact ProAssurance’s investment...

If you have been eyeing Slide Insurance Holdings or already hold some shares, you are probably wondering whether now is a smart time to buy, sell, or simply sit tight. The stock has certainly been on the move, with prices rising 5.2% over the past week and up 14.8% in the last month. That momentum stands in stark contrast to its year-to-date performance, where shares are still down 22.3%. This kind of turnaround often hints at shifting investor sentiment, possibly tied to developments in the...

Thinking about what to do with Fincantieri stock? You are not alone. With price moves that leave most stocks in the dust, it is no wonder investors are curious. Over the past week, Fincantieri’s shares have jumped 22.5%. Stretch that timeline to a year and the return stands at a whopping 453%. Even the most patient, long-term holders have seen gains of 612% over three years and nearly 500% over the last five. Most recently, the company has benefited from broader optimism in European...

Thinking about what to do with Informatica stock? You are not alone. Recent movement in the shares has caught a lot of attention, and there is no shortage of opinions out there. Right now, the stock is hovering near $24.92, and you might notice the numbers are a bit of a mixed bag. Over the past week and month, Informatica has inched up by 0.4% and 0.6% respectively, but if you look at the year-to-date performance, it is down 2.1%. The past year also shows a slight dip, with shares falling...

ClearPoint Neuro recently announced the appointment of Dr. Paul Larson as Chief Medical Officer, the unveiling of its proprietary Robotic Neuro-Navigation System for minimally invasive cranial procedures, and new insider buying from directors. The Robotic Neuro-Navigation System aims to provide greater consistency for cell and gene therapy delivery, and ClearPoint's drug delivery technology was spotlighted in strong Huntington's disease trial results from a biopharma collaborator. Let's...

Bravura Solutions (ASX:BVS) shares are drawing fresh interest after the company raised its annual revenue and profit outlook and named a new CEO. These moves suggest shifting momentum and evolving leadership. See our latest analysis for Bravura Solutions. Bravura’s latest leadership shake-up and raised guidance have prompted the shares to touch fresh 12-month highs, supported by a stronger British pound and improved project revenue in EMEA. While the one-year total shareholder return is just...

Reitar Logtech Holdings recently announced the formal signing of a Strategic Cooperation Memorandum of Understanding with AI logistics company NEXX to jointly invest in a Smart Fulfillment Center project in Doha, Qatar, as part of broad plans for logistics automation in the region. This initiative not only launches a large-scale, AI-driven logistics facility but also aligns with Qatar's 2030 National Vision and the digital corridor ambitions of China's Belt and Road Initiative. We'll explore...

Trying to decide what to do with Miami International Holdings stock? You are not alone. With shares closing recently at $42.09, some investors are feeling bullish, while others are wondering if the momentum can last. Over the past seven days, the stock gained 2.1%, but the 30-day surge of 20.4% is what really has people talking. On a year-to-date basis, Miami International Holdings is up an impressive 36.9%. These kinds of moves often catch the eye of those looking for growth stories or...

If you have been watching Global-E Online's stock and trying to figure out what your next move should be, you are not alone. The company's journey has been anything but boring, with some investors feeling a bit whiplashed by the volatility. After rallying over the past few years, Global-E's share price just logged a 3.7% drop this week, and while the 1-year change sits at -3.3%, there is still that huge 39.3% gain when you look back three years. The downside is that year-to-date, the stock is...